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Dear authors and readers,
While writing the introduction to this issue of FEBS Let-
ters, it is not clear (at least to me) how close we have come to
a complete coverage of the sequence of the human genome
and how many gaps are still left to be ¢lled after all the
available sequence information has been assembled. As im-
portant as these details may be, they are still just details.
No doubt that much more valuable sequence information is
going to be produced in the years to come by both public and
private e¡orts. Genome sequencing, however, is no longer the
main challenge. The focus has now changed from determining
DNA sequences to interpreting the functional information
contained in these monotonous strings of nucleotides.
Everybody anticipates that this second endeavor will be
much tougher than the ¢rst. In 1990 not many of us would
have bet that most of the sequencing of the human genome
could have been completed in less than two years. Even at
that time, however, one could imagine a £ow diagram of the
necessary steps to achieve this goal. The discussion revolved
around the desire to invest heavily in this project rather than
to focus on its feasibility. At that time, the main techniques to
carry out the project had already been established. Despite
several attempts to develop revolutionary approaches that,
in principle, could have speeded up the acquisition of se-
quence information, the dideoxy method of Fred Sanger has
persisted as the main sequencing method, with only minor
modi¢cations to make it compatible with automation.
Genomic sequence information has a value per se. This is
clearly understood by groups working with yeast who, in the
past 3 years, have experienced the value of entering WEB sites
that contain the entire genome of their favorite organism or-
ganized in a user friendly database. In other words, the avail-
ability of the sequence of an entire genome speeds up the
traditional and still very much needed approaches that ad-
dress the function of one or few genes. However, if we limited
our e¡ort to what we are currently doing, albeit at a higher
speed, we would not exploit all the potential of this wealth of
information.
A Medline search for the keywords ‘protein’ and ‘interac-
tion’ returns approximately 500 articles published in 1999.
This provides a rough estimate of the number of new en-
tries/year in the protein interaction database. At this pace,
even with the most optimistic prediction (each of these pub-
lications describes a new protein interaction), it would take
the entire scienti¢c community more than 200 years to discov-
er the partners of the estimated 100 000 peptides encoded in a
single mammalian genome. Clearly, more general, faster and,
at the same time, reliable approaches are needed. At the turn
of the Millennium, reports utilizing novel approaches have
appeared, which describe hundreds to thousands of new in-
teractions with a limited number of experiments and time
investment.
The purpose of this issue is to provide an overview of these
emerging technologies. Some of these are already well estab-
lished and have found their important niche in functional
genomics. Others are still being developed. It is clear that
no single technique is likely to have the same impact on func-
tional genomics that the dideoxy sequencing method has had
on the initial phase of the sequencing project. In fact, one of
the major and most di⁄cult challenges will be the integration
of data obtained through very di¡erent techniques.
When we started to think about a collection of short re-
views on functional genomics, we contemplated covering all
the possible areas. By looking at the contents’ page, it is clear,
despite the high interest in the topics covered, that many
important approaches are missing. These could form the basis
for a new collection of reviews to be published in a forth-
coming issue.
All contributions but one are from European groups. This
does not re£ect the European chauvinism of the editor but is
perhaps a higher appeal, from a European journal of good
tradition, for a European group. In addition, this also re£ects
the leadership of some European groups in the development
of methods for functional genomics. Europe has contributed
substantially to the ¢rst phase of genomics, the Saccharomyces
cerevisiae sequencing project being one of the ¢rst examples in
biology of a large collaboration among several laboratories.
Recently we have witnessed a worldwide change in the scale
of the e¡orts and a £ourishing of new genomic programs and
genomic centers, very few of which are in Europe. It is not
possible to generalize, however, since Europe is not a single
country. We have countries such as Italy, where no integrated
program has been running in the last few years, and where the
few isolated genome projects are supported by charities such
as AIRC (Italian Association for Cancer Research) and Tele-
thon. Alternatively, we have countries such as Britain and
small countries like Denmark that possess relatively strong
programs. The feeling, however, is that Europe in general
risks to lag behind in this important phase of the genome
project unless decisions about investment in this ¢eld are tak-
en soon by the national governments and the European Com-
mission. We hope that the publication of this issue will give a
contribution towards this goal.
Gianni Cesareni
Note from the FEBS Letters Editorial O⁄ce
As demonstrated by this issue dedicated to reviews on func-
tional genomics, FEBS Letters is now interested in publishing
three or four Special Issues per year in addition to our normal
weekly publication. Special Issues could consist of manu-
scripts focused on either (1) opportune topics of su⁄cient
general interest or (2) coverage of signi¢cant meetings/confer-
ences. Please contact Connie Lee (lee@embl-heidelberg.de) at
the FEBS Letters Editorial O⁄ce in Heidelberg if you have
ideas or suggestions for future Special Issues in our journal.
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